Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses
Research and development	$ 1,378,487	$ 938,620
General and administrative	2,152,241	1,998,389
Total operating expenses	3,530,728	2,937,009
Operating loss	(3,530,728)	(2,937,009)
Other expense	(7,341)	(10,411)
Loss before income taxes	(3,538,069)	(2,947,420)
Income taxes
Net loss	$ (3,538,069)	$ (2,947,420)
Loss per common share - basic and diluted (in dollars per share)	$ (0.04)	$ (0.32)
Weighted average shares outstanding - basic and diluted (in shares)	92,587,168	9,130,984